Eagle Asset Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $7.89M | Sell |
313,130
-60,332
| -16% | -$1.52M | 0.04% | 337 |
|
|
2024
Q2 | $4.93M | Sell |
373,462
-65,305
| -15% | -$863K | 0.03% | 395 |
|
|
2024
Q1 | $7.57M | Sell |
438,767
-14,541
| -3% | -$251K | 0.04% | 337 |
|
|
2023
Q4 | $9.87M | Sell |
453,308
-5,861
| -1% | -$128K | 0.05% | 271 |
|
|
2023
Q3 | $7.04M | Buy |
459,169
+8,731
| +2% | +$134K | 0.04% | 310 |
|
|
2023
Q2 | $10.7M | Sell |
450,438
-11,227
| -2% | -$267K | 0.06% | 251 |
|
|
2023
Q1 | $11.7M | Buy |
+461,665
| New | +$11.7M | 0.07% | 225 |
|